世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い

止血剤市場:製品毎(トロンビン、酸化再生セルロース、結合剤、ゼラチン、コラーゲン)、用途毎、地域毎 - 2023年までの世界市場予測

Hemostats Market by Product (Thrombin, Oxidised Regenerated Cellulose, Combination, Gelatin, Collagen), Application (Gynecology, Neurology, Cardiovascular, Reconstructive), Formulation (Powder, Matrix & Gel, Sheets & Pads) - Global Forecast to 2023

 

出版社 出版年月電子版価格 ページ数図表数
MarketsandMarkets
マーケッツアンドマーケッツ
2018年9月US$5,650
シングルユーザライセンス
141 129

サマリー

幅広い市場に関する調査レポートを出版しているマーケッツアンドマーケッツ(MarketsandMarkets)の止血剤市場に関する調査レポートです。

“The global hemostats market is projected to grow at a CAGR of 6.0% during the forecast period.”

The hemostats market is expected to reach USD 3.03 billion by 2023 from USD 2.27 billion in 2018, at a CAGR of 6.0%. Growth in this market is driven by the increasing number of surgical procedures, growing number of regulatory approvals, increasing incidence of sports-related injuries and spinal ailments, and rising focus on effective blood loss management in patients during surgeries.


“In 2018, the thrombin-based hemostats are expected to dominate the hemostats market.”


On the basis of product, the hemostats market is segmented into thrombin-based hemostats, oxidized regenerated cellulose-based hemostats, combination hemostats, gelatin-based hemostats, and collagen-based hemostats. In 2018, the thrombin-based hemostats segment is estimated to hold the largest share of the market. The large share of this segment is attributed to the wide range of advantages associated with the use of thrombin-based hemostats.


“The sponge hemostats segment is estimated to grow at the highest rate in the next five years.”


Based on formulation, the hemostats market has been segmented into matrix & gel hemostats, sheet & pad hemostats, sponge hemostats, and powder hemostats. The sponge hemostats segment is expected to witness the highest growth during the forecast period. The positive growth rate of this segment is attributed to the growing acceptance of these formulations by end users.


“Asia Pacific is estimated to grow at the highest CAGR during the study period.”


Geographically, the hemostats market was dominated by North America, followed by Europe in 2017. However, Asia Pacific is estimated to grow at the highest rate during the forecast period. The improving healthcare infrastructure, growing medical tourism, increasing number of elderly people in the region, and the implementation of favorable government initiatives in several Asian countries, are driving the growth of this region.


The primary interviews conducted for this report can be categorized as follows:


- By Company Type: Tier 1-70%, Tier 2-30%
- By Designation: C level-62%, Director level-21%, Others-17%
- By Region: North America-50%, Europe-20%, Asia Pacific-30%

The key players in the hemostats market include CR Bard, Inc. (US). B. Braun Melsungen AG (Germany), Baxter International, Inc. (US), Integra LifeSciences (US), Marine Polymer Technologies, Inc. (US), Teleflex (US), Ethicon, Inc. (US), Pfizer, Inc. (US), Z-Medica LLC (US), and Gelita Medical GmbH (Germany).

Research Coverage:


The report analyses the hemostats market by product, application, formulation, and region. Apart from a comprehensive geographic product analysis and market sizing, the report also provides a competitive landscape that covers growth strategies adopted by industry players over the last three years. In addition, the company profiles include product portfolios, developments, and strategies adopted by prominent market players to maintain and increase their shares in the hemostats market.


Key Benefits of Buying the Report:


This report will enable both established firms as well as new entrants to gauge the pulse of the market, which in turn will help firms garner greater market shares. Firms purchasing the report can use one, or a combination of the below mentioned five strategies for strengthening their market shares.


The report provides insights on the following pointers:


- Market Penetration: Comprehensive information on the product portfolios of the top players in the hemostats market
- Product Development/Innovation: Detailed insights on upcoming technologies, R&D activities, and product launches in the hemostats market
- Competitive Assessment: In-depth assessment of the market strategies, geographic, and business segments and product portfolios of the leading players in the hemostats market
- Market Development: Comprehensive information about emerging markets. This report analyzes the market for various hemostats products across geographies
- Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the hemostats market



目次

1 INTRODUCTION 14
1.1 OBJECTIVES OF THE STUDY 14
1.2 MARKET DEFINITION 14
1.3 MARKET SCOPE 15
1.3.1 MARKET COVERED 15
1.4 YEARS CONSIDERED FOR THE STUDY 15
1.5 CURRENCY 16
1.6 LIMITATIONS 16
1.7 STAKEHOLDERS 16
2 RESEARCH METHODOLOGY 17
2.1 RESEARCH DATA 17
2.1.1 SECONDARY DATA 18
2.1.1.1 Key data from secondary sources 18
2.1.2 PRIMARY DATA 18
2.1.2.1 Key data from primary sources 19
2.2 MARKET SIZE ESTIMATION 20
2.2.1 BOTTOM-UP APPROACH 20
2.2.2 TOP-DOWN APPROACH 21
2.3 DATA TRIANGULATION METHODOLOGY 22
2.4 ASSUMPTIONS FOR THE STUDY 23
3 EXECUTIVE SUMMARY 24
4 PREMIUM INSIGHTS 27
4.1 HEMOSTATS: MARKET OVERVIEW 27
4.2 ASIA PACIFIC: HEMOSTATS MARKET, BY FORMULATION (2018) 28
4.3 HEMOSTATS MARKET, BY REGION (2018) 29
4.4 GEOGRAPHICAL SNAPSHOT OF THE HEMOSTATS MARKET 30
5 MARKET OVERVIEW 31
5.1 INTRODUCTION 31
5.2 MARKET DYNAMICS 31
5.3 DRIVERS 32
5.3.1 INCREASING NUMBER OF SURGICAL PROCEDURES 32
5.3.2 GROWING NUMBER OF REGULATORY APPROVALS 32
5.3.3 INCREASING INCIDENCE OF SPORTS-RELATED INJURIES AND SPINAL AILMENTS 33
5.3.4 RISING FOCUS ON EFFECTIVE BLOOD LOSS MANAGEMENT IN PATIENTS DURING SURGERIES 33
5.4 MARKET OPPORTUNITIES 33
5.4.1 GROWTH IN THE NUMBER OF HOSPITALS & SURGICAL CENTERS 33
5.4.2 EMERGING MARKETS 34
5.5 MARKET RESTRAINTS 34
5.5.1 PRODUCT RECALLS 34
5.5.2 HIGHLY CONSOLIDATED MARKET 35
5.6 MARKET CHALLENGES 35
5.6.1 DEARTH OF SKILLED PERSONNEL 35
5.6.2 HIGH COST OF HEMOSTATS 36
6 HEMOSTATS MARKET, BY PRODUCT 37
6.1 INTRODUCTION 38
6.2 THROMBIN-BASED HEMOSTATS 39
6.3 OXIDIZED REGENERATED CELLULOSE-BASED HEMOSTATS 40
6.4 COMBINATION HEMOSTATS 41
6.5 GELATIN-BASED HEMOSTATS 42
6.6 COLLAGEN-BASED HEMOSTATS 43
7 HEMOSTATS MARKET, BY FORMULATION 45
7.1 INTRODUCTION 46
7.2 MATRIX & GEL HEMOSTATS 47
7.3 SHEET & PAD HEMOSTATS 48
7.4 SPONGE HEMOSTATS 49
7.5 POWDER HEMOSTATS 50
8 HEMOSTATS MARKET, BY APPLICATION 51
8.1 INTRODUCTION 52
8.2 ORTHOPEDIC SURGERY 53
8.3 GENERAL SURGERY 54
8.4 NEUROLOGICAL SURGERY 55
8.5 CARDIOVASCULAR SURGERY 56
8.6 RECONSTRUCTIVE SURGERY 57
8.7 GYNECOLOGICAL SURGERY 58
8.8 OTHER SURGERIES 59
-
9 HEMOSTATS MARKET, BY REGION 61
9.1 INTRODUCTION 62
9.2 NORTH AMERICA 63
9.2.1 US 67
9.2.2 CANADA 68
9.3 EUROPE 70
9.3.1 GERMANY 73
9.3.2 UK 74
9.3.3 FRANCE 75
9.3.4 ITALY 77
9.3.5 SPAIN 78
9.3.6 RUSSIA 79
9.3.7 SWITZERLAND 81
9.3.8 BELGIUM 82
9.3.9 REST OF EUROPE 83
9.4 ASIA PACIFIC 84
9.4.1 CHINA 87
9.4.2 JAPAN 88
9.4.3 INDIA 90
9.4.4 AUSTRALIA 91
9.4.5 SINGAPORE 92
9.4.6 NEW ZEALAND 94
9.4.7 SOUTH KOREA 95
9.4.8 INDONESIA 96
9.4.9 MALAYSIA 98
9.4.10 REST OF ASIA PACIFIC 99
9.5 LATIN AMERICA 100
9.5.1 BRAZIL 102
9.5.2 MEXICO 104
9.5.3 REST OF LATIN AMERICA 105
9.6 MIDDLE EAST AND AFRICA 107
10 COMPETITIVE LANDSCAPE 110
10.1 OVERVIEW 110
10.2 MARKET SHARE ANALYSIS 111
10.3 COMPETITIVE SCENARIO 112
10.3.1 PRODUCT LAUNCHES AND APPROVALS 112
10.3.2 ACQUISITIONS 113
10.3.3 AGREEMENTS 113
10.3.4 EXPANSIONS 113
-
11 COMPANY PROFILES 114
(Introduction, Products & Services, Strategy, & Analyst Insights, Developments, MnM View)*
11.1 C. R. BARD 114
11.2 B.BRAUN 116
11.3 BAXTER 118
11.4 INTEGRA LIFESCIENCES 120
11.5 MARINE POLYMER TECHNOLOGIES 122
11.6 PFIZER 123
11.7 GELITA MEDICAL GMBH 125
11.8 Z-MEDICA, LLC 126
11.9 ETHICON (SUBSIDIARY OF JOHNSON & JOHNSON) 128
11.10 TELEFLEX INCORPORATED 130

*Details on MarketsandMarkets view, Introduction, Product & Services, Strategy, & Analyst Insights, New Developments might not be captured in case of unlisted companies.
12 APPENDIX 132
12.1 INSIGHTS OF INDUSTRY EXPERTS 132
12.2 DISCUSSION GUIDE 133
12.3 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 137
12.4 AVAILABLE CUSTOMIZATIONS 139
12.5 RELATED REPORTS 139
12.6 AUTHOR DETAILS 140

 

LIST OF TABLES

TABLE 1 HEMOSTATS MARKET, BY PRODUCT, 2016-2023 (USD MILLION) 38
TABLE 2 HEMOSTATS MARKET, BY PRODUCT, 2016-2023 (THOUSAND UNITS) 39
TABLE 3 THROMBIN-BASED HEMOSTATS MARKET, BY REGION, 2016-2023 (USD MILLION) 39
TABLE 4 THROMBIN-BASED HEMOSTATS MARKET, BY REGION,
2016-2023 (THOUSAND UNITS) 40
TABLE 5 OXIDIZED REGENERATED CELLULOSE-BASED HEMOSTATS MARKET,
BY REGION, 2016-2023 (USD MILLION) 40
TABLE 6 OXIDIZED REGENERATED CELLULOSE-BASED HEMOSTATS MARKET,
BY REGION, 2016-2023 (THOUSAND UNITS) 41
TABLE 7 COMBINATION HEMOSTATS MARKET, BY REGION, 2016-2023 (USD MILLION) 41
TABLE 8 COMBINATION HEMOSTATS MARKET, BY REGION, 2016-2023 (THOUSAND UNITS) 42
TABLE 9 GELATIN-BASED HEMOSTATS MARKET, BY REGION, 2016-2023 (USD MILLION) 42
TABLE 10 GELATIN-BASED HEMOSTATS MARKET, BY REGION,
2016-2023 (THOUSAND UNITS) 43
TABLE 11 COLLAGEN-BASED HEMOSTATS MARKET, BY REGION, 2016-2023 (USD MILLION) 43
TABLE 12 COLLAGEN-BASED HEMOSTATS MARKET, BY REGION,
2016-2023 (THOUSAND UNITS) 44
TABLE 13 HEMOSTATS MARKET, BY FORMULATION, 2016-2023 (USD MILLION) 46
TABLE 14 MATRIX & GEL HEMOSTATS MARKET, BY REGION, 2016-2023 (USD MILLION) 47
TABLE 15 SHEET & PAD HEMOSTATS MARKET, BY REGION, 2016-2023 (USD MILLION) 48
TABLE 16 SPONGE HEMOSTATS MARKET, BY REGION, 2016-2023 (USD MILLION) 49
TABLE 17 POWDER HEMOSTATS MARKET, BY REGION, 2016-2023 (USD MILLION) 50
TABLE 18 HEMOSTATS MARKET, BY APPLICATION, 2016-2023 (USD MILLION) 52
TABLE 19 HEMOSTATS MARKET FOR ORTHOPEDIC SURGERY, BY REGION,
2016-2023 (USD MILLION) 53
TABLE 20 HEMOSTATS MARKET FOR GENERAL SURGERY, BY REGION,
2016-2023 (USD MILLION) 54
TABLE 21 HEMOSTATS MARKET FOR NEUROLOGICAL SURGERY,
BY REGION, 2016-2023 (USD MILLION) 55
TABLE 22 HEMOSTATS MARKET FOR CARDIOVASCULAR SURGERY,
BY REGION, 2016-2023 (USD MILLION) 56
TABLE 23 HEMOSTATS MARKET FOR RECONSTRUCTIVE SURGERY,
BY REGION, 2016-2023 (USD MILLION) 57
TABLE 24 COUNTRIES WITH THE HIGHEST C-SECTION RATE (2015) 58
TABLE 25 HEMOSTATS MARKET FOR GYNECOLOGICAL SURGERY,
BY REGION, 2016-2023 (USD MILLION) 59
TABLE 26 HEMOSTATS MARKET FOR OTHER SURGERIES, BY REGION,
2016-2023 (USD MILLION) 60
TABLE 27 HEMOSTATS MARKET, BY REGION, 2016-2023 (USD MILLION) 63
TABLE 28 NORTH AMERICA: HEMOSTATS MARKET, BY COUNTRY, 2016-2023 (USD MILLION) 65
TABLE 29 NORTH AMERICA: HEMOSTATS MARKET, BY PRODUCT, 2016-2023 (USD MILLION) 65
TABLE 30 NORTH AMERICA: HEMOSTATS MARKET, BY PRODUCT,
2016-2023 (THOUSAND UNITS) 65
TABLE 31 NORTH AMERICA: HEMOSTATS MARKET, BY FORMULATION,
2016-2023 (USD MILLION) 66
TABLE 32 NORTH AMERICA: HEMOSTATS MARKET, BY APPLICATION,
2016-2023 (USD MILLION) 66
TABLE 33 US: HEMOSTATS MARKET, BY PRODUCT, 2016-2023 (USD MILLION) 67
TABLE 34 US: HEMOSTATS MARKET, BY PRODUCT, 2016-2023 (THOUSAND UNITS) 68
TABLE 35 CANADA: HEMOSTATS MARKET, BY PRODUCT, 2016-2023 (USD MILLION) 69
TABLE 36 CANADA: HEMOSTATS MARKET, BY PRODUCT, 2016-2023 (THOUSAND UNITS) 69
TABLE 37 EUROPE: HEMOSTATS MARKET, BY COUNTRY, 2016-2023 (USD MILLION) 70
TABLE 38 EUROPE: HEMOSTATS MARKET, BY PRODUCT, 2016-2023 (USD MILLION) 71
TABLE 39 EUROPE: HEMOSTATS MARKET, BY PRODUCT, 2016-2023 (THOUSAND UNITS) 71
TABLE 40 EUROPE: HEMOSTATS MARKET, BY FORMULATION, 2016-2023 (USD MILLION) 72
TABLE 41 EUROPE: HEMOSTATS MARKET, BY APPLICATION, 2016-2023 (USD MILLION) 72
TABLE 42 GERMANY: HEMOSTATS MARKET, BY PRODUCT, 2016-2023 (USD MILLION) 73
TABLE 43 GERMANY: HEMOSTATS MARKET, BY PRODUCT, 2016-2023 ( THOUSAND UNITS) 73
TABLE 44 UK: HEMOSTATS MARKET, BY PRODUCT, 2016-2023 (USD MILLION) 74
TABLE 45 UK: HEMOSTATS MARKET, BY PRODUCT, 2016-2023 (THOUSAND UNITS) 75
TABLE 46 FRANCE: HEMOSTATS MARKET, BY PRODUCT, 2016-2023 (USD MILLION) 76
TABLE 47 FRANCE: HEMOSTATS MARKET, BY PRODUCT, 2016-2023 (THOUSAND UNITS) 76
TABLE 48 ITALY: HEMOSTATS MARKET, BY PRODUCT, 2016-2023 (USD MILLION) 77
TABLE 49 ITALY: HEMOSTATS MARKET, BY PRODUCT, 2016-2023 (THOUSAND UNITS) 77
TABLE 50 SPAIN: HEMOSTATS MARKET, BY PRODUCT, 2016-2023 (USD MILLION) 78
TABLE 51 SPAIN: HEMOSTATS MARKET, BY PRODUCT, 2016-2023 (THOUSAND UNITS) 79
TABLE 52 RUSSIA: HEMOSTATS MARKET, BY PRODUCT, 2016-2023 (USD MILLION) 80
TABLE 53 RUSSIA: HEMOSTATS MARKET, BY PRODUCT, 2016-2023 (THOUSAND UNITS) 80
TABLE 54 SWITZERLAND: HEMOSTATS MARKET, BY PRODUCT, 2016-2023 (USD MILLION) 81
TABLE 55 SWITZERLAND: HEMOSTATS MARKET, BY PRODUCT,
2016-2023 (THOUSAND UNITS) 81
TABLE 56 BELGIUM: HEMOSTATS MARKET, BY PRODUCT, 2016-2023 (USD MILLION) 82
TABLE 57 BELGIUM: HEMOSTATS MARKET, BY PRODUCT, 2016-2023 (THOUSAND UNITS) 82
TABLE 58 ROE: HEMOSTATS MARKET, BY PRODUCT, 2016-2023 (USD MILLION) 83
TABLE 59 ROE: HEMOSTATS MARKET, BY PRODUCT, 2016-2023 (THOUSAND UNITS) 83
TABLE 60 ASIA PACIFIC: HEMOSTATS MARKET, BY COUNTRY, 2016-2023 (USD MILLION) 84
TABLE 61 ASIA PACIFIC: HEMOSTATS MARKET, BY PRODUCT, 2016-2023 (USD MILLION) 85
TABLE 62 ASIA PACIFIC: HEMOSTATS MARKET, BY PRODUCT,
2016-2023 (THOUSAND UNITS) 85
TABLE 63 ASIA PACIFIC: HEMOSTATS MARKET, BY FORMULATION,
2016-2023 (USD MILLION) 86
TABLE 64 ASIA PACIFIC: HEMOSTATS MARKET, BY APPLICATION, 2016-2023 (USD MILLION) 86
TABLE 65 CHINA: HEMOSTATS MARKET, BY PRODUCT, 2016-2023 (USD MILLION) 87
TABLE 66 CHINA: HEMOSTATS MARKET, BY PRODUCT, 2016-2023 (THOUSAND UNITS) 88
TABLE 67 JAPAN: HEMOSTATS MARKET, BY PRODUCT, 2016-2023 (USD MILLION) 89
TABLE 68 JAPAN: HEMOSTATS MARKET, BY PRODUCT, 2016-2023 (THOUSAND UNITS) 89
TABLE 69 INDIA: HEMOSTATS MARKET, BY PRODUCT, 2016-2023 (USD MILLION) 90
TABLE 70 INDIA: HEMOSTATS MARKET, BY PRODUCT, 2016-2023 (THOUSAND UNITS) 91
TABLE 71 AUSTRALIA: HEMOSTATS MARKET, BY PRODUCT, 2016-2023 (USD MILLION) 91
TABLE 72 AUSTRALIA: HEMOSTATS MARKET, BY PRODUCT, 2016-2023 (THOUSAND UNITS) 92
TABLE 73 SINGAPORE: HEMOSTATS MARKET, BY PRODUCT, 2016-2023 (USD MILLION) 93
TABLE 74 SINGAPORE: HEMOSTATS MARKET, BY PRODUCT, 2016-2023 (THOUSAND UNITS) 93
TABLE 75 NEW ZEALAND: HEMOSTATS MARKET, BY PRODUCT, 2016-2023 (USD MILLION) 94
TABLE 76 NEW ZEALAND: HEMOSTATS MARKET, BY PRODUCT,
2016-2023 (THOUSAND UNITS) 94
TABLE 77 SOUTH KOREA: HEMOSTATS MARKET, BY PRODUCT, 2016-2023 (USD MILLION) 95
TABLE 78 SOUTH KOREA: HEMOSTATS MARKET, BY PRODUCT,
2016-2023 (THOUSAND UNITS) 96
TABLE 79 INDONESIA: HEMOSTATS MARKET, BY PRODUCT, 2016-2023 (USD MILLION) 97
TABLE 80 INDONESIA: HEMOSTATS MARKET, BY PRODUCT, 2016-2023 (THOUSAND UNITS) 97
TABLE 81 MALAYSIA: HEMOSTATS MARKET, BY PRODUCT, 2016-2023 (USD MILLION) 98
TABLE 82 MALAYSIA: HEMOSTATS MARKET, BY PRODUCT, 2016-2023 (THOUSAND UNITS) 98
TABLE 83 ROAPAC: HEMOSTATS MARKET, BY PRODUCT, 2016-2023 (USD MILLION) 99
TABLE 84 ROAPAC: HEMOSTATS MARKET, BY PRODUCT, 2016-2023 (THOUSAND UNITS) 99
TABLE 85 LATIN AMERICA: HEMOSTATS MARKET, BY COUNTRY, 2016-2023 (USD MILLION) 100
TABLE 86 LATIN AMERICA: HEMOSTATS MARKET, BY PRODUCT, 2016-2023 (USD MILLION) 100
TABLE 87 LATIN AMERICA: HEMOSTATS MARKET, BY PRODUCT,
2016-2023 (THOUSAND UNITS) 101
TABLE 88 LATIN AMERICA: HEMOSTATS MARKET, BY FORMULATION,
2016-2023 (USD MILLION) 101
TABLE 89 LATIN AMERICA: HEMOSTATS MARKET, BY APPLICATION,
2016-2023 (USD MILLION) 102
TABLE 90 BRAZIL: KEY MACROINDICATORS FOR THE HEMOSTATS MARKET 102
TABLE 91 BRAZIL: HEMOSTATS MARKET, BY PRODUCT, 2016-2023 (USD MILLION) 103
TABLE 92 BRAZIL: HEMOSTATS MARKET, BY PRODUCT, 2016-2023 (THOUSAND UNITS) 103
TABLE 93 MEXICO: HEMOSTATS MARKET, BY PRODUCT, 2016-2023 (USD MILLION) 104
TABLE 94 MEXICO: HEMOSTATS MARKET, BY PRODUCT, 2016-2023 (THOUSAND UNITS) 105
TABLE 95 REST OF LATIN AMERICA: HEMOSTATS MARKET, BY PRODUCT,
2016-2023 (USD MILLION) 105
TABLE 96 REST OF LATIN AMERICA: HEMOSTATS MARKET, BY PRODUCT,
2016-2023 (THOUSAND UNITS) 106
TABLE 97 MIDDLE EAST AND AFRICA: HEMOSTATS MARKET, BY COUNTRY,
2016-2023 (USD MILLION) 107
TABLE 98 MIDDLE EAST AND AFRICA: HEMOSTATS MARKET, BY PRODUCT,
2016-2023 (USD MILLION) 108
TABLE 99 MIDDLE EAST AND AFRICA: HEMOSTATS MARKET, BY PRODUCT,
2016-2023 (THOUSAND UNITS) 108
TABLE 100 MIDDLE EAST AND AFRICA: HEMOSTATS MARKET, BY FORMULATION,
2016-2023 (USD MILLION) 109
TABLE 101 MIDDLE EAST AND AFRICA: HEMOSTATS MARKET, BY APPLICATION,
2016-2023 (USD MILLION) 109

 

LIST OF FIGURES

FIGURE 1 RESEARCH METHODOLOGY 17
FIGURE 2 BREAKDOWN OF PRIMARY INTERVIEWS 19
FIGURE 3 BOTTOM-UP APPROACH 20
FIGURE 4 TOP-DOWN APPROACH 21
FIGURE 5 DATA TRIANGULATION 22
FIGURE 6 HEMOSTATS MARKET, BY PRODUCT, 2018 VS. 2023 (USD MILLION) 24
FIGURE 7 HEMOSTATS MARKET, BY FORMULATION, 2018 VS. 2023 (USD MILLION) 25
FIGURE 8 HEMOSTATS MARKET, BY APPLICATION, 2018 VS. 2023 (USD MILLION) 25
FIGURE 9 HEMOSTATS MARKET, BY REGION, 2018 VS. 2023 (USD MILLION) 26
FIGURE 10 INCREASING NUMBER OF SURGICAL PROCEDURES IS EXPECTED
TO DRIVE MARKET GROWTH 27
FIGURE 11 MATRIX AND GEL HEMOSTATS ARE EXPECTED TO COMMAND
THE LARGEST MARKET SHARE IN 2018 28
FIGURE 12 NORTH AMERICA IS EXPECTED TO HOLD THE LARGEST SHARE
OF THE HEMOSTATS MARKET IN 2018 29
FIGURE 13 INDIA TO REGISTER THE HIGHEST CAGR DURING THE FORECAST PERIOD 30
FIGURE 14 HEMOSTATS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 31
FIGURE 15 COMBINATION HEMOSTATS TO WITNESS THE HIGHEST GROWTH IN THE HEMOSTATS MARKET DURING THE FORECAST PERIOD 38
FIGURE 16 SPONGE HEMOSTATS TO WITNESS THE HIGHEST GROWTH DURING
THE FORECAST PERIOD 46
FIGURE 17 RECONSTRUCTIVE SURGERY TO WITNESS THE HIGHEST GROWTH DURING THE FORECAST PERIOD 52
FIGURE 18 NORTH AMERICA TO DOMINATE THE GLOBAL HEMOSTATS MARKET IN 2018 62
FIGURE 19 NORTH AMERICA: HEMOSTATS MARKET SNAPSHOT 64
FIGURE 20 KEY DEVELOPMENTS OF MAJOR PLAYERS FROM 2015 TO 2018 110
FIGURE 21 HEMOSTATS MARKET SHARE ANALYSIS, BY KEY PLAYERS, 2017 111
FIGURE 22 C. R. BARD: COMPANY SNAPSHOT (2016) 114
FIGURE 23 B. BRAUN: COMPANY SNAPSHOT (2017) 116
FIGURE 24 BAXTER: COMPANY SNAPSHOT (2017) 118
FIGURE 25 INTEGRA LIFESCIENCES: COMPANY SNAPSHOT (2017) 120
FIGURE 26 PFIZER: COMPANY SNAPSHOT (2017) 123
FIGURE 27 JOHNSON & JOHNSON SERVICES, INC.: COMPANY SNAPSHOT (2017) 128
FIGURE 28 TELEFLEX INCORPORATED: COMPANY SNAPSHOT (2017) 130

 

ページTOPに戻る

プレスリリース

[プレスリリース原文]

Hemostats Market worth $3.03 billion by 2023


September 10, 2018

The report "Hemostats Market by Product (Thrombin, Oxidised Regenerated Cellulose, Combination, Gelatin, Collagen), Application (Gynecology, Neurology, Cardiovascular, Reconstructive), Formulation (Powder, Matrix & Gel, Sheets & Pads) - Global Forecast to 2023", The hemostats market is expected to reach USD 3.03 billion by 2023 from USD 2.27 billion in 2018, at a CAGR of 6.0%.

Growth in this market is driven by the increasing number of surgical procedures, growing number of regulatory approvals, increasing incidence of sports-related injuries and spinal ailments, and rising focus on effective blood loss management in patients during surgeries. In addition, the emerging markets and growth in the number of hospitals and surgical centers are expected to offer further growth opportunities for players operating in the hemostats market. On the other hand, high cost of hemostats and dearth of skilled professionals are expected to hinder the growth of this market.

The thrombin-based hemostats segment is expected to account for the largest share of the market in 2018.

Based on product, the hemostats market is segmented into thrombin-based hemostats, oxidized regenerated cellulose-based hemostats, combination hemostats, gelatin-based hemostats, and collagen-based hemostats. Of all these product segments, the thrombin-based hemostats segment is expected to account for the largest share of the global hemostats market in 2018. The large share of this market segment can primarily be attributed to the wide range of advantages associated with the use of thrombin-based hemostats.

In 2018, the orthopedic surgery segment is expected to dominate the hemostats market

On the basis of application, the hemostats market is segmented neurological surgery, cardiovascular surgery, general surgery, orthopedic surgery, gynecological surgery, reconstructive surgery, and other surgeries. The orthopedic surgery segment is expected to account for the largest share of the hemostats market in 2018. The growing geriatric population, increasing incidence of sports injuries, and the growing prevalence of lifestyle disorders (such as arthritis, osteoporosis, and obesity) are some of the major factors responsible for the growth in the number of orthopedic surgeries performed globally. The growing number of orthopedic surgeries is in turn expected to support the growth of dependent markets, such as the hemostats market for orthopedic applications.

In 2018, North America to command for the largest market share

On the basis of region, the hemostats market is segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. In 2018, North America is expected to account for the largest share of the global hemostats market. The hemostats market in North America is well-established, with the US being a major market in this region. Growth in the North American market is majorly driven by the growing geriatric population and increasing number of surgeries in the region.

The major players in the hemostats market include CR Bard, Inc. (US), B. Braun Melsungen AG (Germany), Baxter International, Inc. (US), Integra LifeSciences (US), Marine Polymer Technologies, Inc. (US), Teleflex (US), Ethicon, Inc. (US), Pfizer, Inc. (US), Z-Medica LLC (US), and Gelita Medical GmbH (Germany).

 

あなたが最近チェックしたレポート一覧

  • 最近チェックしたレポートはありません。

お問合は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのお問合せはこちらのフォームから承ります

このレポートへのお問合せ

03-3582-2531

電話お問合せもお気軽に

<無料>メルマガに登録する

 

 

ページTOPに戻る